Korsana Biosciences, Inc. (KRSA) Earnings History
Net Loss9 years of earnings data (2017–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Korsana Biosciences, Inc. (KRSA) Earnings Overview
As of November 8, 2026, Korsana Biosciences, Inc. (KRSA) reported trailing twelve-month net income of -$7M, reflecting +9.9% year-over-year growth. The company earned $-11.04 per diluted share over the past four quarters, with a net profit margin of -170.1%.
Looking at the long-term picture, KRSA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$3M in fiscal 2024.
Korsana Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ADMA ($182M net income, 28.8% margin), IMVT (-$538M net income), KALA (-$10M net income), KRSA has room to improve margins relative to the peer group. Compare KRSA vs ADMA →
KRSA Earnings vs Peers
Earnings metrics vs comparable public companies
KRSA Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$4M | -15.4% | -$5M | $-7.63 | -170.1% | -239.8% |
| 2024 | -$3M | +41.9% | -$4M | $-8.47 | -152.8% | -181.4% |
| 2023 | -$5M | +88.1% | -$13M | $-62.93 | - | - |
| 2022 | -$44M | +14.7% | -$19M | $-141.05 | -14841.1% | -6242.4% |
| 2021 | -$52M | +33.6% | -$55M | $-184.80 | -1555.6% | -1662.5% |
| 2020 | -$78M | +36.8% | -$81M | $-334.60 | -3388.6% | -3539.4% |
| 2019 | -$123M | -6.7% | -$125M | $-618.59 | -2729.3% | -2774.3% |
| 2018 | -$115M | -22.7% | -$115M | $-590.94 | - | - |
| 2017 | -$94M | - | -$94M | $-481.60 | - | - |
Download Data
Export KRSA earnings history in CSV or JSON format
Free sign-in required to download data
KRSA Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
KRSA — Frequently Asked Questions
Quick answers to the most common questions about buying KRSA stock.
What is KRSA earnings per share (EPS)?
KRSA trailing twelve-month (TTM) diluted EPS is $-11.04, reflecting +9.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2017 to 2025 is available in the table on this page.
What is Korsana Biosciences, Inc.'s net income?
Korsana Biosciences, Inc. (KRSA) trailing twelve-month net income is $-7M as of 2025. Earnings grew +9.9% year-over-year.
Is KRSA profitable?
KRSA is not currently profitable on a TTM basis, reporting a net loss of $-7M. Net margin is -170.1%. Investors should monitor for a return to profitability.
What is KRSA's earnings growth rate?
KRSA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2025.
What are KRSA's profit margins?
Korsana Biosciences, Inc. net profit margin is -170.1%, operating margin is -239.8%, and gross margin is +100.0%. Below-average margins reflect competitive or cost pressures. Return on Equity is -39.3%.
Is KRSA growing earnings?
KRSA is growing earnings steadily. YoY EPS growth of +9.9% is consistent with the 5-year CAGR of N/A. TTM net income is $-7M.
What was KRSA's best earnings year?
Korsana Biosciences, Inc.'s highest annual net income on record is $-3M, achieved in fiscal year 2024. Earnings history on this page spans 2017 to 2025 and includes all annual and quarterly figures.
What were KRSA's earnings last quarter?
KRSA's most recent reported quarter was Q2 2026. Net income was $-2M with diluted EPS of $-2.87. For a full breakdown of all quarters, see the quarterly earnings table on this page.